4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2024 / Narrative review
This review examines the relationships between incretin hormones, gut microbiota, and obesity. Gastrointestinal incretins such as GIP and GLP-1 are secreted following nutrient intake and impact lipid metabolism, gastric emptying, appetite, and body weight. The gut microbiota influences host metabolism by modulating incretin secretion via enteroendocrine cells, with microbial metabolites like short-chain fatty acids and indole directly stimulating incretin release. Additionally, incretin-based therapies and bariatric surgery are associated with increases in gut bacterial richness and diversity.
Angelini G, Russo S, Mingrone G Peptides, 2024. PMID 38636809
2023 / Review
Obesity is a major public health concern associated with conditions like hypertension, type 2 diabetes, stroke, and cancer, affecting over a third of adults in the United States. While standard pharmacological agents such as lipase inhibitors and GLP-1 receptor agonists reduce weight gain by inhibiting fat absorption or stimulating satiety hormones, they are not effective for genetic disorders like Bardet-Biedl syndrome or POMC deficiency. Emerging therapies, including leptin analogs and MC4R agonists, target these genetic or hormonal causes to help regulate energy balance and appetite. The review discusses clinical trials, efficacy, FDA-approved indications, contraindications, and serious side effects of these medication classes.
Brandfon S, Eylon A, Khanna D, et al. Cureus, 2023. PMID 37937009
2022 / Narrative review
This review examines the physiological functions of GLP-1 and its development into pharmaceuticals for obesity and type 2 diabetes (T2DM). GLP-1 receptor agonists are highlighted as effective anti-obesity agents and recommended second-line therapies for T2DM, particularly for patients with increased cardiovascular risk. The author discusses proglucagon processing across tissues and notes that the relationship between endogenous GLP-1 actions and the clinical effects of agonists is far from congruent and generally poorly understood.
Holst JJ J Intern Med, 2022. PMID 34982496
2020 / Narrative review
This review explores the bioactivity, clinical application, phytochemicals, products, markets, and patents related to fenugreek. More than 100 phytochemicals have been isolated from fenugreek seeds, mainly comprising polysaccharides, saponins, alkaloids, phenolic acids, and flavonoids. Fenugreek extract and its bioactive compounds showed antidiabetic and anti-obesity activity in both animal and human studies. The authors note that China currently lacks research on fenugreek in both depth and width.
Yao D, Zhang B, Zhu J, et al. Crit Rev Food Sci Nutr, 2020. PMID 31286789
2020 / Narrative review
This review examined studies addressing mortality, health-span, and longevity-enhancing mechanisms in vegans and vegetarians. Epidemiologic studies consistently show lower disease rates, such as lower cancer and cardiovascular disease incidence, but mortality rates are comparable to vegetarians and occasional meat eaters. Vegan diets improve insulin resistance and dyslipidemia, and features like protein restriction or amino acid restriction (leucine or methionine) show potential life-span-enhancing effects. The review notes that vegan diets do not meet the nutritional requirements of children, pregnant women, or elderly individuals without adequate supplementation.
Shows an association, not proof of cause and effect.
Norman K, Klaus S Curr Opin Clin Nutr Metab Care, 2020. PMID 31895244
2020 / Narrative review / methodological commentary
This commentary assesses the NutriRECS consortium's recommendations on red and processed meat, arguing their evaluation relied on GRADE criteria primarily designed for clinical drug trials rather than dietary exposures. Applying the NutriGRADE system, the evidence on the positive association between red and processed meats and type 2 diabetes was rated 'high quality,' and the association with mortality was rated 'moderate quality.' The authors note NutriRECS's evaluation also suffered from inadequate attention to what foods replace red meat, such as plant-based proteins or refined carbohydrates.
Shows an association, not proof of cause and effect.
Qian F, Riddle MC, Wylie-Rosett J, et al. Diabetes Care, 2020. PMID 31959642
2020 / Narrative review
This review examines the potential of a whole food plant-based (WFPB) diet to ameliorate chronic kidney disease (CKD). Evidence suggests a WFPB diet may slow CKD progression, decrease cardiovascular disease incidence, lower rates of diabetes and obesity, and reduce inflammation and cholesterol, thereby delaying kidney failure and dialysis initiation. Plant-based protein is reported to be alkaline-producing, anti-inflammatory, and renoprotective, contrasting with animal protein which promotes acidity, inflammation, and hyperfiltration. The authors note that macronutrient and micronutrient content must be carefully adjusted to prevent malnutrition, and further research is required to confirm biological plausibility and feasibility in CKD patients.
Adair KE, Bowden RG Nutrients, 2020. PMID 32268544
2020 / Guideline
The American Cancer Society updated its Diet and Physical Activity Guideline based on current scientific evidence regarding dietary and physical activity patterns and cancer risk. The guideline presents 4 recommendations for individual choices alongside recommendations for community action to create supportive environments. These recommendations align with prevention guidelines for coronary heart disease and diabetes from the American Heart Association and the American Diabetes Association.
Rock CL, Thomson C, Gansler T, et al. CA Cancer J Clin, 2020. PMID 32515498
2020 / Narrative review
This review examined literature from PubMed, guideline reports, and newer publications regarding hypertension and COVID-19 in African Americans. It highlights that the increased prevalence and risks of hypertension are primarily due to environmental and lifestyle factors, such as poor diet and adverse social determinants. Blood pressure control can be supported through lifestyle changes, including a low-sodium diet, weight loss, and physical activity, alongside pharmacological or novel treatments when needed. Additionally, existing comorbidities like hypertension and obesity contribute to worse COVID-19 outcomes in this population.
Ferdinand K, Batieste T, Fleurestil M J Natl Med Assoc, 2020. PMID 32563685
2020 / Narrative review with systematic search
This narrative review systematically searched and appraised studies examining associations between ultra-processed food (UPF) intake and health outcomes in healthy participants. Out of 43 reviewed studies, 37 found UPF exposure was associated with at least one adverse health outcome. In adults, reported associations included overweight, obesity, cardio-metabolic risks, cancer, type-2 diabetes, cardiovascular diseases, irritable bowel syndrome, depression, frailty conditions, and all-cause mortality; in children and adolescents, outcomes included cardio-metabolic risks and asthma. No study reported an association between UPF and beneficial health outcomes, and the authors note that most findings were derived from observational studies.
Shows an association, not proof of cause and effect.
Elizabeth L, Machado P, Zinöcker M, et al. Nutrients, 2020. PMID 32630022
2019 / Narrative review
Following a James Lind Alliance survey identifying diabetes reversal as the top research priority among people with type 2 diabetes, this review summarizes current evidence on weight loss-induced remission. Current data indicate long-term stable β-cell function occurs if weight regain is prevented, whereas returning to previous weight leads to recurrence. The review also notes that the chance of achieving reversal steadily diminishes with increasing duration of type 2 diabetes.
Taylor R, Barnes AC Diabet Med, 2019. PMID 30378706
2019 / Narrative review
This review discusses clinical and pathophysiological studies showing that type 2 diabetes is largely driven by reversible fat accumulation in the liver and pancreas. Removal of this excess fat through substantial weight loss can normalize hepatic insulin responsiveness and allow recovery of acute insulin secretion by beta cells, normalizing blood glucose. In the primary care-based DiRECT trial, weight loss mediated type 2 diabetes remission in 46% of individuals at 12 months and 36% at 24 months.
Taylor R, Al-Mrabeh A, Sattar N Lancet Diabetes Endocrinol, 2019. PMID 31097391
2019 / Case report and literature review
A 54-year-old female presenting with grade 3 obesity (BMI 45.2 kg/m2), type II diabetes (A1c 8.1%), and heart failure with depressed left ventricular systolic function transitioned to a whole food plant-based diet alongside guideline-directed medical therapy. Over five and a half months, she lost 22.7 kg, reversed her diabetes without diabetes medications, and normalized her left ventricular systolic function. The authors noted that causality cannot be determined from this case report.
Allen KE, Gumber D, Ostfeld RJ Front Nutr, 2019. PMID 31245377
2019 / Narrative review
A review of epidemiologic and biochemical evidence evaluated trans fatty acid (TFA) intake and chronic disease risks. A 2% absolute increase in energy intake from trans fat has been associated with a 23% increase in cardiovascular risk. TFAs increase low-density lipoprotein levels, and several epidemiological studies demonstrate that high TFA intake increases the incidence of cancer and diabetes. Complete elimination of TFAs is not possible in a balanced diet due to their natural presence in dairy and meat products.
Shows an association, not proof of cause and effect.
Islam MA, Amin MN, Siddiqui SA, et al. Diabetes Metab Syndr, 2019. PMID 31336535
2019 / Narrative review
This review evaluated the evidence on plant-based diets and health outcomes, examining how these benefits translate to Black individuals in the United States. Although substantial evidence supports plant-based diets in the general population, little research has focused specifically on Black populations. Available data suggest that plant-based diets may reduce the risk of heart disease and possibly cancer in this group. The authors note that more research is needed on cardiovascular risk factors, cancer subtypes, and other chronic diseases, emphasizing the need for culturally appropriate interventions.
Shows an association, not proof of cause and effect.
Sterling SR, Bowen SA Nutrients, 2019. PMID 31810250
2019 / Updated systematic review of meta-analyses
An updated electronic search of PubMed/MEDLINE, CINAHL, and Cochrane Library identified seven new meta-analyses examining nut consumption and cardiometabolic diseases. Comparing high with low consumption categories, nut intake significantly decreased CVD mortality (-19% to -25%; n = 4), CHD mortality (-24% to -30%; n = 3), stroke mortality (-17% to -18%; n = 3), CVD incidence (-15% to -19%; n = 4), CHD/CAD incidence (-17% to -34%; n = 8), and stroke incidence (-10% to -11%; n = 6). Compared with control diets, nut consumption significantly reduced fasting glucose (0.08 to 0.15 mmol/L; n = 6), total cholesterol (0.021 to 0.30 mmol/L; n = 10), and LDL-C (0.017 to 0.26 mmol/L; n = 10). Body weight and blood pressure were not significantly affected.
Shows an association, not proof of cause and effect.
Kim Y, Keogh JB, Clifton PM Int J Environ Res Public Health, 2019. PMID 31817639
2019 / Narrative review
Atrial fibrillation affects an estimated 34 million individuals globally and carries a significant burden of morbidity and mortality. This review examines evidence regarding the use of a whole-food plant-based diet—emphasizing grains, legumes, vegetables, fruits, and nuts while excluding most or all animal products—for managing atrial fibrillation risk factors. It highlights effects on cardiovascular and metabolic factors including hypertension, coronary artery disease, diabetes, obesity, inflammation, and subclinical atherosclerosis.
Storz MA, Helle P J Arrhythm, 2019. PMID 31844466
2018 / Case-based review
This article discusses two clinical cases and reviews practical approaches to managing obesity and type 2 diabetes, focusing on non-surgical metabolic rehabilitation. The authors note that referral to a multidisciplinary outpatient program may be necessary for more complicated patients, and it is not uncommon for patients to lose between 10-20% of their initial weight. Despite this, metabolic surgery may be required for further weight loss and long-term maintenance. Based on clinical experience, the authors suggest intensive, multidisciplinary rehabilitation with supervised exercise as the gold standard of care.
Bishay RH, Kormas N Curr Diabetes Rev, 2018. PMID 28359235
2018 / Narrative review / commentary
This article discusses the role of lifestyle choices in health and chronic disease prevention. It notes that approximately 80% of chronic disease and premature death could be prevented by avoiding smoking, engaging in physical activity, and following a healthful dietary pattern. Cardiovascular disease, diabetes, stroke, dementia, and cancer are all influenced by lifestyle. The author argues for a global coalition of experts to clarify confusing nutrition messages and promote health-promoting diet and lifestyle patterns.
Katz DL, Frates EP, Bonnet JP, et al. Am J Health Promot, 2018. PMID 28523941
2018 / Narrative review
This review describes the practice of lifestyle medicine and its impact on chronic diseases such as cardiovascular disease, cancer, and type 2 diabetes. The authors highlight that most chronic illnesses stem from poor nutrition and physical inactivity. They discuss the economic benefits of prevention-based lifestyle medicine and argue that it should become the primary approach to managing and preventing chronic conditions.
Bodai BI, Nakata TE, Wong WT, et al. Perm J, 2018. PMID 29035175
2018 / Narrative review
This review summarizes published in vitro, ex vivo, animal, and human studies regarding the nutritional value and health benefits of ancient wheat varieties such as emmer, einkorn, spelt, khorasan, and regional Italian varieties. Existing in vivo evidence indicates beneficial effects on cardio-metabolic markers, including lipid and glycaemic profiles, alongside inflammatory and oxidative status. However, findings from in vitro studies remain mixed, and due to a limited number of human trials, it cannot be definitively concluded that ancient varieties are superior to modern wheats in reducing chronic disease risk.
Dinu M, Whittaker A, Pagliai G, et al. J Nutr Biochem, 2018. PMID 29065353
2018 / Narrative review
This review details research using a low-energy diet to elucidate and reverse pathophysiological changes in type 2 diabetes. Negative energy balance triggers a profound fall in liver fat content, normalizing hepatic insulin sensitivity within 7 days. Continued negative energy balance lowers liver triacylglycerol export and raised pancreas fat content, re-establishing normal first-phase insulin secretion and plasma glucose control in early type 2 diabetes. A structured 'One, Two' approach of weight loss followed by weight maintenance has enabled motivated individuals to reverse type 2 diabetes and remain normoglycaemic over years.
Taylor R, Barnes AC Diabetologia, 2018. PMID 29143063
2018 / Narrative review
This review evaluates evidence regarding the circadian regulation of glucose, lipid, and energy metabolism in humans. Studies using diverse experimental protocols report circadian rhythms in glucose, insulin, glucose tolerance, lipid levels, energy expenditure, and appetite, with several peaking in the biological morning or around noon. The authors review evidence indicating that circadian misalignment induced by mistimed light exposure, sleep, or food intake adversely affects metabolic health, underscoring the importance of chronobiology for preventing and treating type 2 diabetes, obesity, and hyperlipidemia.
Poggiogalle E, Jamshed H, Peterson CM Metabolism, 2018. PMID 29195759
2018 / Review of randomized controlled trials and other studies
This review evaluated evidence from randomized controlled trials and other studies on caloric restriction (CR) and cardiovascular parameters. CR was found to significantly improve blood pressure (BP), heart rate variability, arterial stiffness, endothelial dysfunction, and flow-mediated arterial dilatation, allowing patients to discontinue antihypertensive medication without becoming hypotensive. Benefits were seen regardless of age, sex, weight, BMI, or metabolic conditions, with the greatest benefits in the sickest individuals. Exercise enhanced the effects of CR only in hypertensive subjects, while proposed mechanisms include improved insulin sensitivity, increased nitric oxide production, and SIRT1 induction.
Nicoll R, Henein MY Int J Mol Sci, 2018. PMID 29518898